Torsten Kniess' Publications

2020ORCHID ID 0000-0002-4107-3455

2024

• Kreller, M.; Brühlmann, S.A.; Knieß, T.; Kopka, K.; Walther, M.; Production of Medical Radionuclides in the Center for Radiopharmaceutical Tumor Research - A Status Report. Instruments, 2024, 8, 10.

2023

• Knieß, T.; Kreller, M.; Zessin, J.; Kopka, K.; Elektrophile Synthese von 6-L-[¹⁸F]FDOPA mit [¹⁸F]F₂: ein Statusbericht über das Gastarget am Zyklotron TR-Flex. Nuklearmedizin, 2023, 62, 150.
• Mäding, P.; Zessin, J.; Kreller, M.; Kopka, K.; Kniess, T.; Actions for increased yields and easier maintenance at the Tracerlab FXC-pro system in the synthesis of L-[¹¹C]methionine. EJNMMI Radiopharmacy and Chemistry, 2023, 8 (Suppl. 1), 11
• Brühlmann, S.A.; Walther, M.; Kreller, M.; Reissig, F.; Pietzsch, H.J.; Kniess, T.; Kopka, K.; Cyclotron-Based Production of 67-Cu for Radionuclide Theranostics via the ⁷⁰Zn(p,α)⁶⁷Cu Reaction. Pharmaceuticals, 2023, 16, 314.
• Kniess, T.; Zessin, J.; Mäding, P.; Kuchar, M., Kiss, O.; Kopka, K.; Synthesis of [¹⁸F]FMISO, a hypoxia-specific imaging probe for PET, an overview from a radiochemist's perspective. EJNMMI Radiopharmacy and Chemistry, 2023, 8: 5

2020

• Laube, M.; Gassner, C.; Neuber, C.; Wodtke, R.; Ullrich, M.; Haase-Kohn, C.; Löser, R.; Köckerling, M.; Kopka, K.; Kniess, T.; Hey-Hawkins, E.; Pietzsch, J.; Deuteration versus ethylation - strategies to improve the metabolic fate of an 18F-labeled celecoxib derivative. RSC Advances, 2020, 10, 38601-38611.
  

2019

• Roscales, S.; Kniess, T.; Access to ¹⁸F-labelled isoxazoles by ruthenium-promoted 1,3-dipolar cycloaddition of 4-[¹⁸F]fluoro-N-hydroxybenzimidoyl chloride with alkynes. J Label Compd Radiopharm 2019, 62, 393-403.
• Laube, M.; Kniess, T.; Neuber, C.; Haase-Kohn, C.; Pietzsch, J.; Fluorine-18 Labeling of S100 Proteins for Small Animal Positron Emission Tomography. Methods in Molecular Biology, vol.1929, https://doi.org/10.1007/978-1-4939-9030-6_29.
• Roscales, S.; Bechmann, N.; Pietzsch, J.; Kniess, T.; One-pot cascade synthesis of pyrazole based isosteres of valdecoxib by a [3+2] cycloaddition sequence and evaluation of their COX inhibitory activity. Heterocycles, 2019, 98, 3, 416-428.
• Laube, M.; Gassner, C.; Kniess, T.; Pietzsch, J.; Synthesis and Cyclooxygenase Inhibition of Sulfonamide-Substituted  (Dihydro)Pyrrolo[3,2,1-hi]indoles and Their Potential Prodrugs. Molecules, 2019, 24, 3807.
• Kreller, M.; Pietzsch, H.J.; Walther, M.; Tietze, H.; Kaever, P.; Knieß, T.; Füchtner, F.; Steinbach, J.; Preusche, S.; Introduction of the New Center for Radiopharmaceutical Cancer Research at Helmholtz-Zentrum Dresden-Rossendorf. Instuments 2019, 3, 9; https://doi.org/10.3390/instruments3010009.
• Bechmann, N.; Kniess, T.; Pietzsch, J.; Nitric Oxide-Releasing Selective Estrogen Receptor Modulators: A Bifunctional Approach to Improve the Therapeutic Index. J Med Chem, 2019, 62, 6525-6539.

2018

• Kranz, M.; Bergmann, R.; Kniess, T.; Belter, B.; Neuber, C.; Cai, Z.; Deng, G.; Fischer, S.; Zhou, J.; Huang, Y.; Brust, P.; Deuther-Conrad, W.; Pietzsch, J.; Bridging from Brain to Tumor Imaging: (S)(-)- and (R)(+)-[¹⁸F]Fluspidine for Investigation of Sigma-1 Receptors in Tumor-Bearing Mice. Molecules 2018, 23, 702.
• Roscales, S.; Bechmann, N.; Weiss, D.H.; Köckerling, M.; Pietzsch, J.; Kniess, T.; Novel valdecoxib derivatives by ruthenium(II)-promoted 1,3-dipolar cycloaddition of nitrile oxides with alkynes - synthesis and COX-2 inhibition activity. MedChemComm 2018, 9, 534-544.

2017

• Kniess, T.; Laube, M.; Wüst, F.; Pietzsch, J.; Technetium-99m based small molecule radiopharmaceuticals and radiotracers targeting inflammation and infection. DaltonTrans 2017, 46, 14435-14451.
• Kniess, T.; Laube, M., Steinbach, J.; "Hydrous ¹⁸F-fluoroethylation"- Leaving off the azeotropic drying. Appl Radiat Isot 2017, 127, 260-268.
• Moldovan, R.P.; Els-Heindl, S.; Worm, D.J.; Kniess, T.; Kluge, M.; Beck-Sickinger A.G.; Deuther-Conrad, W.; Krügel, U.; Brust, P.; Development of Fluorinated Non-Ghrelin Receptor Ligands for Potential Use in Molecular Imaging. Int J Mol Sci 2017, 18, 768.

2016

• Laube, M.; Kniess, T.; Pietzsch, J.; Development of Antioxidant COX-2 Inhibitors as Radioprotective Agents for Radiation Theraphy - A Hypothesis-Driven Review. Antioxidants 2016, 5, DOI 10.3390/antiox5020014.
• Gassner, C.; Neuber, C.; Laube, M.; Bergmann, R.; Kniess, T.; Pietzsch, J.; Development of a ¹⁸F-labeled Diaryl-Substituted Dihydropyrrolo[3,2,1-hi]indole as Potential Probe for Functional Imaging of Cyclooxygenase-2 with PET. ChemistrySelect 2016, 1, 5812-5820.